Directory
>
Michelle Blake
Michelle Blake
Vice President, Translational Sciences | Sonoma Biotherapeutics
Seattle, Washington, United States
Michelle Blake
Summary
Michelle Blake is a seasoned leader in the biopharmaceutical industry with extensive experience in drug development, particularly in translational sciences. Currently serving as Vice President at Sonoma Biotherapeutics, she spearheads research initiatives focused on innovative therapies for oncology. With a Ph.D. in Pathology from the University of Washington, Michelle has a strong technical background in various areas including immunology, biomarker development, and drug discovery. Her career spans several prominent organizations, where she has held leadership roles that emphasize her expertise in CAR-T therapies and antibody technologies. Notably, she contributed to the approval of significant drug products during her tenure at Amgen. Michelle is passionate about advancing translational medicine and is committed to bridging the gap between research and clinical application. Her ability to lead cross-functional teams and manage complex projects has been a hallmark of her professional journey, making her a key player in the biotherapeutics landscape.
Michelle Blake
Work Experience
Vice President, Translational Sciences at
Sonoma Biotherapeutics
October 2021 - Present
Senior Director at
Shape Therapeutics Inc.
April 2020 - October 2021
Director, Immuno-oncology & Cellular Therapy Translational Sciences at
Bristol Myers Squibb
March 2018 - March 2020
Principal Scientist, Biomarkers at
Bristol Myers Squibb
July 2016 - March 2018
Senior Manager, Diagnostics & Biomarkers at
Seagen
November 2015 - June 2016
Lead Scientist Translational Research at
Emergent BioSolutions
September 2014 - October 2015
Senior Scientist Biomarkers at
ImmunoGen, Inc.
January 2014 - August 2014
Associate Director, Pharmacology at
Agios Pharmaceuticals
May 2012 - January 2014
Senior Scientist at
Amgen, Inc.
January 2005 - October 2011
Scientist at
Amgen, Inc.
July 2004 - December 2004
Postdoctoral Fellow at
Amgenimmunex
January 2002 - January 2004
Michelle Blake
Education
University of Washington, Ph.D.
January 1995 - January 2001
California Polytechnic State University, San Luis Obispo, Bachelor Of Science
January 1989 - January 1993
Frequently Asked Questions about Michelle Blake
What is Michelle Blake email address?
Michelle Blake's primary email address is **************@waikato.ac.nz. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Michelle Blake work for?
Michelle Blake is a Vice President, Translational Sciences at Sonoma Biotherapeutics, a company specializing in Commercial physical research.
Where Michelle Blake graduated from?
Michelle Blake holds a degree in Pathology from University of Washington.
How can I directly contact Michelle Blake?
To contact Michelle Blake directly, you can use the email address **************@waikato.ac.nz. Complete contact information is available upon registration with Muraena.
Who is Michelle Blake?
Michelle Blake is a seasoned leader in the biopharmaceutical industry with extensive experience in drug development, particularly in translational sciences. Currently serving as Vice President at Sonoma Biotherapeutics, she spearheads research initiatives focused on innovative therapies for oncology. With a Ph.D. in Pathology from the University of Washington, Michelle has a strong technical background in various areas including immunology, biomarker development, and drug discovery. Her career spans several prominent organizations, where she has held leadership roles that emphasize her expertise in CAR-T therapies and antibody technologies. Notably, she contributed to the approval of significant drug products during her tenure at Amgen. Michelle is passionate about advancing translational medicine and is committed to bridging the gap between research and clinical application. Her ability to lead cross-functional teams and manage complex projects has been a hallmark of her professional journey, making her a key player in the biotherapeutics landscape.
Michelle`s contact details
**************@waikato.ac.nz
******@sonomabio.com
Colleagues
Vice President, Intellectual Property and Legal Operations
Vice President Clinical Operations
Vice President Discovery
Vice President, Program Leadership
Vice President
VP Program Management
Vice President, Head Of Quality
Chief Legal Officer & Secretary
Vice President Of Business Development
Chief Scientific Officer